GET THE APP

Strategies for Achieving the Goals of a Lung-Protective Ventilation Protocol in Large Clinical Trials
Journal of Clinical Trials

Journal of Clinical Trials
Open Access

ISSN: 2167-0870

+44 20 3868 9735

Research Article - (2011) Volume 1, Issue 1

Strategies for Achieving the Goals of a Lung-Protective Ventilation Protocol in Large Clinical Trials

Friedemann J. H. Taut1, Gordana Bothe1, Peter Schenk2, Nathan Dean3, Kenneth Krell4, Andreas Günther5, James F. Lewis6 and Roger G. Spragg7*
1Nycomed GmbH, Konstanz, Germany, E-mail: [email protected]
2Department of Internal Medicine III, General Hospital Vienna, Vienna, Austria, E-mail: [email protected]
3Intermountain Medical Center, Murray, UT, USA, E-mail: [email protected]
4Eastern Idaho Medical Center, Idaho Falls, ID, USA, E-mail: [email protected]
5Department of Pulmonary and Critical Care, Justus-Liebig-University, Giessen, Germany, E-mail: [email protected]
6St Joseph’s Health Center, University of Western Ontario, London, Ontario, Canada, E-mail: [email protected]
7Division of Pulmonary and Critical Care Medicine, University of California San Diego, San Diego VA Healthcare System, La Jolla, CA, USA, E-mail: [email protected]
*Corresponding Author: Roger G. Spragg, MD, VA Medical Center - 151A, 3350 La Jolla Village Drive, San Diego, CA, 92161, USA, Tel: +1 858-642-1248, Fax: +1 858-552-7592 Email:

Abstract

Background: Standardizing patient care is a challenging task in studies of patients with acute illness. Use of a lung-protective ventilation (LPV) protocol in studies of patients with acute lung injury is associated with reduced mortality and is the current standard for invasive ventilation in such studies. However, achieving the goals of an LPV protocol can be challenging. Methods: In a Phase III clinical study of pulmonary surfactant administration to patients with acute respiratory insufficiency due to pneumonia or aspiration of gastric contents, we performed an observational analysis to assess whether the goals of a specified ventilation protocol were achieved. Ventilation parameters, including tidal volume (VT) and peak inspiratory pressure (PIP), of the first 200 patients enrolled were analyzed. Subsequently, an intensified training program was initiated to improve achievement of protocol goals, and this achievement was assessed again in the next 643 randomized patients. Results: Implementation of intensified training measures was accompanied by a significant reduction in median values of VT from 7.8 to 7.0 mL/kg predicted body weight (PBW) and PIP from 29.5 to 28.5 cm H2O. Use of VT based on actual body weight, as opposed to PBW, may impair goal achievement. Goal achievement varied among countries and improved significantly in some with intensified training measures. Conclusions: Specific training measures may be effective in promoting achievement of goals of a pre-specified ventilation protocol in multinational clinical trials. Strategies described in this study may be helpful in achieving compliance with complex protocol demands in a variety of clinical trials.

Keywords: Clinical trial; Multicenter trials; Critical illness; Pulmonary surfactant

Abbreviations

ABW: Actual Body Weight; APACHE II: Acute Physiological and Chronic Health Evaluation II; ARDS: Acute Respiratory Distress Syndrome; FiO2: fraction of inspired oxygen; ICH: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; LPV: Lung-Protective Ventilation; PaO2: partial pressure of arterial oxygen; PBW: predicted body weight; PEEP: positive end-expiratory pressure; PIP: peak inspiratory pressure; SECB: Scientific Enrollment Coordination Board; SOFA: Sequential Organ Failure Assessment; VT: Tidal Volume

Introduction

Standardization of care in studies of critically ill patients is challenging. This is particularly true for mechanical ventilation. Although mechanical ventilation plays an important part in the treatment of acute respiratory failure, it can cause lung injury when alveoli are over-distended by high tidal volume (VT) or high inflation pressures [1,2]. Such ventilator-induced lung injury results in inflammatory responses that cause further damage to the lungs [3-5].

Numerous studies have investigated different strategies to minimize the adverse impact of mechanical ventilation on patients’ lungs, but only a protocol-based lung-protective ventilation (LPV) strategy has resulted in significant improvement in survival [6]. However, despite the clear benefit of LPV, many patients with acute lung injury have received mechanical ventilation with VTs above the goal of 6 mL/kg predicted body weight (PBW) [4,7-13].

Within multinational clinical trials, achievement of LPV protocol goals has been variable. For example, in the STRIVE study, goal achievement was excellent (mean VT 6.8 mL/kg PBW) [14], whereas in several subsequent clinical trials it was less favorable (mean VTs of 8.4 to 8.8 mL/kg PBW) [13,15].

Such variability in achieving LPV goals and conflicting reports of concordance between trials and clinical practice demonstrate that standardization of patient care remains a challenge in studies of critically ill patients [16,17].

As pointed out by Cooke et al, there has been no investigation of factors that promote adherence to an LPV protocol [18]. To encourage investigation in this area, we have conducted an observational analysis of data from the VALID study, a randomized Phase III investigation of the benefit of intratracheal instillation of a surfactant suspension (Venticute®; Nycomed GmbH, Konstanz, Germany) to patients with pneumonia or aspiration of gastric contents who are intubated and mechanically ventilated [19].

In this study the use of the Acute Respiratory Distress Syndrome (ARDS) Network LPV protocol was strongly recommended. However, after the initial analysis of the first 200 patients, it became apparent there was a need for further training measures to reduce VT levels to the recommended values. Here we describe: changes in achieving goals of a LPV protocol that were observed after implementing intensified training measures; the variability among countries in initial and post-training choice of VT; and the discrepancy caused by use of actual body weight (ABW) as opposed to PBW.

Methods

Study description

The VALID study (clinicaltrials.gov identifier: NCT00074906) was a randomized, parallel-group, double-blind, controlled study enrolling patients with lung injury in 161 medical centers in 22 countries conducted from November 2003 to March 2008. Trial design, patient characteristics, and outcome measures have been published previously [19].

The following ARDS Network LPV protocol items were emphasized in the protocol for the VALID study:

- Ventilation with low VT of 6 mL/kg PBW, plateau pressure goal ≤ 30 cm H2O

- Arterial oxygenation goal of PaO2 55 to 80 mmHg (equal to 7.3 to 10.7 kPa) or oxygen saturation 88% to 95%

- FiO2 and PEEP combinations as described in ARDS Network ventilation protocol [6]

Training measures

Initial training measures: The VALID study protocol required that use of the ARDS Network ventilation protocol be emphasized at initial site visits and investigator’s meetings before patients were enrolled at each center. Adherence to the ARDS recommendations in terms of VT and arterial oxygenation goals were strongly recommended as part of the initial training measures. However, patient-specific details of the volume or pressure-controlled ventilation were at the discretion of the treating physician.

Intensified training measures: To encourage improved adherence to the ARDS Network ventilation protocol, four intensified training methods were used as part of the VALID study, subsequent to observations that demonstrated an opportunity for improved adherence to the LPV protocol during the study of the first 200 patients.

1. Teleconferences were organized with investigators at the initiation of the intensive training measures. Updates on the progress of lowering VT were emailed to all investigators every 6 months and on occasion of national and international investigators’ meetings as they occurred.

2. Data regarding the magnitude and distribution of VTs used at specific study sites were disclosed to the investigators at those sites during visits by the clinical research associate (which occurred when study patient data were collected) and/or during the sponsor’s study site visits. These data, as well as those aggregated by country, were presented and discussed with the investigators, with the request to more closely adhere to the VT goals, if necessary.

3. Just prior to patient enrollment, site investigators were required to discuss patient suitability for the study with a physician member of the trial Scientific Enrollment Coordination Board (SECB). The function and operation of this Board has been described previously [20]. Discrepancies between the recommended patient-specific VT and the VT actually being delivered to the patient were discussed with the study site investigator as part of the intensified training measures.

4. Case report form data, including ventilation parameters from 26 time points during the first 5 days of the study, were entered into the sponsor’s database. Data on ventilation parameters that deviated from the recommended LPV protocol values were used to provide feedback to the study sites and maintain awareness. For 576 patients (68.3% of the study population) a median of five (1 to 11 [25% to 75% quartile]) time points with a VT >8 mL/kg PBW was identified. One summary query for each of these patients was then issued to the relevant site.

Observational assessments

To assess achievement of LPV protocol goals, VT and peak inspiratory pressure (PIP) were measured at the beginning and end of the 2-hour baseline period before randomization. Values were averaged for individual patients. Although measurement of plateau pressures would have been preferable, standardized methodology across the 161 participating centers was not achieved. Investigators were requested to avoid, if possible, changes in ventilator settings during the baseline period. Achievement of the ARDS Network LPV protocol goals was assessed in consecutively enrolled patients before (patients 1 to 200) and after (patients 201 to 843) intensified training measures were implemented. Median VT during the study was calculated for each country that had enrolled at least 12 randomized patients. Comparison of median baseline VT per kg PBW and per kg ABW was undertaken. Each study patient contributed one pair of values. For display, the patients were sorted by VT/kg ABW and the corresponding value for VT/kg PBW was plotted above or below it.

Statistical analyses

Descriptive statistical analysis was performed, including mean ± standard deviation and 90%, 75%, 50%, 25%, and 10% percentiles. The Cochran-Armitage Trend Test was used to compare the frequency distribution of VT at baseline. The regression coefficient for trend of VT in cohorts of 200 consecutively enrolled patients (243 for the last cohort) was tested using a t-test. All other comparisons between ‘prior to intensified training measures’ (patients 1 to 200) and ‘with intensified training measures’ (patients 201 to 843) were performed using the two-sided Wilcoxon test.

Results

The demographic characteristics for the 843 patients randomized in the VALID study have been published previously [19]. For all enrolled patients, the mean PaO2/FiO2 ratio was 123.9 ± 0.93 mmHg, and 58.6% of these patients had ARDS at baseline as previously defined by the American European Consensus Conference criteria [21]. Patients with unilateral opacities on the chest radiograph were not categorized as having ARDS. Pneumonia was the most common cause of acute lung failure, occurring in 728 (86.4%) of patients.

Box plots of distribution of VT at baseline in 18 countries are shown in Figure 1 and demonstrate wide differences in VT among countries. Patients in Estonia (median of 6.1 mL/kg PBW), New Zealand, Russia, and Denmark received the lowest VT, followed by Austria, Germany, Argentina, and Spain (median< 7.0 mL/kg PBW). VT goal achievement in other countries was less favorable, with seven countries having a median baseline VT of > 7.5 mL/kg PBW. The countries with the highest median VT were Canada and Switzerland (8.1 mL/kg PBW). Intensified training measures improved VT goal achievement in several countries. In the USA, mean VT was significantly lower following the implementation of intensified training than prior to training (7.3 mL/ kg PBW vs 8.5 mL/kg PBW; p=0.0003). Other countries for which statistically significant improvement in VT goal achievement were observed included Australia (p=0.0113), Belgium (p=0.0087), Germany (p=0.0345), and Hungary (p=0.0031).

clinical-trials-Median-tidal-volume

Figure 1: Median tidal volume (VT) of patients in different countries. Boxes indicate 25% and 75% of all values with median as horizontal line, whiskers indicate 10% and 90% of all values, arrowheads indicate means. Number of enrolled patients per country are given in parentheses. PBW, predicated body weight.

Overall, achievement of the ARDS Network LPV protocol VT goal was significantly improved after intensified training compared with pretraining adherence (Figure 2). For the first 200 patients treated before intensified training, median (25th to 75th percentile) VT at baseline was 7.8 (6.6 to 9.0) mL/kg PBW compared with 7.0 (6.2 to 8.0) mL/kg PBW in the 643 patients treated after initiation of intensified training (p<0.0001). Immediately after implementation of the intensified training measures, median VT decreased to 7.4 mL/kg PBW (patients 201 to 400). With continuation of training efforts, median VT continued to decrease to 7.1 mL/kg PBW in the next 200 patients (up to patient 600), and to 6.7 mL/kg in the following 243 patients (up to patient 843; p<0.0001 (Figure 2)), indicating ongoing decline over time. Furthermore, patients were more likely to be ventilated with a VT consistent with the ARDS Network LPV protocol after intensified training measures had been applied (patients 201 to 843; p<0.001 (Figure 3)).

clinical-trials-Change-tidal-volume

Figure 2: Change in tidal volume (VT) with intensified training measures. Boxes indicate 25% and 75% of all values with median as horizontal line, whiskers indicate 10% and 90% of all values, arrowheads indicate means. Patients are sorted in chronological order of enrollment. After training VT was significantly decreased; this decrease was progressive over time (p < 0.0001). PBW, predicated body weight.

clinical-trials-Frequency-distribution-tidal-volume

Figure 3: Frequency distribution of tidal volume (VT) prior to intensified training (dark bars, patients 1 to 200) and after initiation of intensified training measures (light bars, patients 201 to 600). Difference between groups is significant, p < 0.0001. PBW, predicated body weight.

For each individual patient, VT was calculated on the basis of ABW and the values were sorted by VT/kg ABW. These values were plotted in ascending order, starting with the patient with the lowest VT/kg ABW. This resulted in a sigmoid distribution curve. We then calculated the VT of each patient based on PBW and added these values to the graph. The resultant scatter plot indicates that using ABW is misleading because it frequently results in VT values considerably lower or higher than the appropriately calculated VT using PBW (Figure 4).

clinical-trials-Frequency-baseline-tidal-volume

Figure 4: Cumulative distribution of baseline tidal volume (VT) calculated by actual body weight (ABW). VT (mL/kg ABW; closed diamonds) were calculated for each patient and are plotted in ascending order. For comparison, the VT based on the predicted body weight (PBW) was also calculated for each patient and data are indicated by open triangles.

Median (25th to 75th percentile) PIP at baseline was reduced from 29.5 (25.0 to 34.5) cm H2O before intensified training to 28.5 (23.5 to 32.5) cm H2O (p=0.002) after intensified training (Figure 5).

clinical-trials-peak-inspiratory-pressure

Figure 5: Change in peak inspiratory pressure (PIP) with intensified training measures. Boxes indicate 25% and 75% of all values with median as horizontal line, whiskers indicate 10% and 90% of all values, arrowheads indicate the mean. Patients are sorted in chronological order of enrollment.

Discussion

Site investigators in this multinational study were advised to comply with the ARDS Network LPV protocol. After the first 200 patients had been enrolled into the study, it became apparent that compliance with this protocol, particularly with use of VT of 6 mL/ kg PBW, could be improved. While no specific measures have been shown prospectively to be effective [18] evidence supports the use of multifaceted interventions that include education, reminders, and feedback [22]. For this reason, four specific training interventions were implemented. These provided: real-time reminders to the site investigator at the time of patient enrollment to use the appropriate VT; feedback that reported the VTs actually used by that investigator as well as by investigators in different countries; feedback focusing on use of excessive VTs; and regular teleconferences and mailings designed to provide ongoing education. In a small, retrospective study, Wolthuis et al. [23] suggested that such measures may promote adherence to an LPV protocol.

Achievement of LPV protocol VT goal improved after implementing training measures, as reflected by a fall in median VT from 7.8 mL/kg PBW (patients 1 to 200) to 7.0 mL/kg PBW (patients 201 to 843), and to 6.7 mL/kg PBW in the final cohort reported (patients 601 to 843). One can question whether this modest change is of clinical relevance; however, the point of this observational study was to identify strategies that improved achievement of the LPV protocol goals. The training measures that were implemented here were accompanied by a 44% reduction in median VT delivered in excess of the goal of 6.0 mL/kg PBW. In addition, these training measures also were accompanied by a small but significant decrement in PIP.

Our observations have several limitations that deserve comment. First, they are uncontrolled and indeed it is ethically impossible to purposefully under-train study site investigators on an intervention thought to improve patient survival. However, our observations are based on a large number of patients and on the care delivered at 161 sites in 22 countries. While it is possible that achievement of the VT goal of the ARDS Network LPV protocol may have improved internationally and independently of our intensified training measures, we believe that such an abrupt improvement, coincident with the implementation of these measures, would be unlikely.

A second limitation is absence of measurements of inspiratory plateau pressure. The LPV protocol that was recommended in the VALID trial called for achieving a plateau pressure less than 30 cm H2O. Unfortunately, methods for measuring plateau pressure were not standardized across the 22 countries participating in the study, and the only reliable measurements of pressure that are available for analysis are those of PIP. PIP is reported to exceed plateau pressure by approximately 5-7 cm H2O in patients with ALI [24]. It is likely that the reduction in PIP noted after the implementation of intensified training measures reflects a true decrement in plateau pressure.

A third limitation is the absence of information on the ventilatory mode used, and specifically if more patients were managed with volume control ventilation after the interventions.

We observed considerable variation in baseline VT among the participating countries. A retrospective study analyzing 149 patients in two hospitals in the USA reported a mean VT of 7.6 (standard deviation 2.1) mL/kg PBW on the first day [11]. Interestingly, they reported a hospital mortality of 41%, which compares with a mortality of 32% reported in another observational study that adhered to the ARDS Network protocol in an equivalent patient population [25]. The authors suggested that these differences in mortality may be partly attributable to the less rigorous adherence to the ARDS Network goal of a VT of 6 mL/kg PBW [11].

In the conduct of a large multinational study of patients with severe lung injury, achieving adherence to an LPV protocol at multiple sites in multiple countries is challenging. As the study end point is often mortality, and mortality is significantly affected by the ventilation strategy, such adherence is critical. In the STRIVE study, investigators were successful in standardizing ventilator management across 105 institutions in six countries with enrollment of 429 patients with acute lung injury, achieving a median VT of 6.5 mL/kg PBW [14]. The VALID study, covering 161 centers in 22 countries, was significantly larger, with increased difficulty of assuring compliance to the LPV protocol. Achieving a median VT within target range after implementing intensified training measures may provide a temporary benchmark for studies of this magnitude.

Low-stretch ventilation is now considered the current standard of care in the treatment of patients with acute lung injury or ARDS [8,27], and a clearly stated LPV management strategy should be considered for inclusion in study protocols. This observational study describes methods that promote achievement of the goals of a LPV protocol. Given the direct impact of ventilation protocols on mortality, the most significant end point in studies of critically ill patients, continuing attention must be given to methods of optimizing achievement of LPV protocol goals.

Conclusion

In a large multicenter international study, compliance with the ARDS Network LPV protocol was inconsistent, resulting in significant variation of delivered VTs among 161 sites in 22 countries. Implementation of specific training measures was accompanied by improved achievement of LPV protocol goals, with a lowering of the median VT and PIP and a narrowing of the variation of the VT values.

Clinical trials involving patients with acute respiratory failure require adherence to a LPV protocol. Intensive measures to improve achievement of protocol goals may be of value.

Funding

The VALID study was sponsored by Nycomed GmbH, Konstanz, Germany. Funding for the analysis described in this manuscript consisted of salary support by Nycomed GmbH for authors affiliated with that company. The sponsor provided full information to the senior author (Dr. Spragg) who wrote the manuscript. The decision to submit the manuscript for publication was not determined by the sponsor.

Acknowledgements

All authors have reviewed and take full responsibility for the content of the manuscript. They gratefully acknowledge the statistical support of Markus Roters, PhD, Omnicare Clinical Research, Cologne, Germany, and the editorial assistance of Lynda Chang, PhD, Complete HealthVizion, Glasgow, UK. Editorial assistance was funded by a grant from Nycomed GmbH.

References

  1. Dreyfuss D, Soler P, Basset G, Saumon G (1988) High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 137: 1159-1164.
  2. Slutsky AS (1999) Lung injury caused by mechanical ventilation. Chest 116: 9S-15S.
  3. Parker JC, Hernandez LA, Peevy KJ (1993) Mechanisms of ventilator-induced lung injury. Crit Care Med 21: 131-143.
  4. Sakr Y, Vincent JL, Reinhart K, Groeneveld J, Michalopoulos A, et al. (2005) High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest 128: 3098-3108.
  5. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS (1997) Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 99: 944-952.
  6. (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342: 1301-1308.
  7. Gillis RC, Weireter LJ Jr, Britt RC, Cole FJ Jr, Collins JN, et al. (2007) Lung protective ventilation strategies: have we applied them in trauma patients at risk for acute lung injury and acute respiratory distress syndrome? Am Surg 73: 347-350.
  8. Brower RG, Ware LB, Berthiaume Y, Matthay MA (2001) Treatment of ARDS. Chest 120: 1347-1367.
  9. Fan E, Needham DM, Stewart TE (2005) Ventilatory management of acute lung injury and acute respiratory distress syndrome. JAMA 294: 2889-2896.
  10. Weinert CR, Gross CR, Marinelli WA (2003) Impact of randomized trial results on acute lung injury ventilator therapy in teaching hospitals. Am J Respir Crit Care Med 167: 1304-1309.
  11. Seeley E, McAuley DF, Eisner M, Miletin M, Matthay MA, et al. (2008) Predictors of mortality in acute lung injury during the era of lung protective ventilation. Thorax 63: 994-998.
  12. Young MP, Manning HL, Wilson DL, Mette SA, Riker RR, et al. (2004) Ventilation of patients with acute lung injury and acute respiratory distress syndrome: has new evidence changed clinical practice? Crit Care Med 32: 1260-1265.
  13. Gattinoni L, Caironi P, Cressoni M, Chiumello D, Ranieri VM, et al. (2016) Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 354: 1775-1786.
  14. Zeiher BG, Artigas A, Vincent J-L, Dmitrienko A, Jackson K, et al. (2004) Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 32: 1695-1702.
  15. Kesecioglu J, Beale R, Stewart TE, Findlay GP, Rouby JJ, et al. (2009) Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 180: 989-994.
  16. Dennison CR, Mendez-Tellez PA, Wang W, Pronovost PJ, Needham DM (2007) Barriers to low tidal volume ventilation in acute respiratory distress syndrome: survey development, validation, and results. Crit Care Med 35: 2747-2754.
  17. Deans KJ, Minneci PC, Suffredini AF, Danner RL, Hoffman WD, et al. (2007) Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols. Crit Care Med 35: 1509-1516.
  18. Cooke CR, Kahn JM, Watkins TR, Hudson LD, Rubenfeld GD (2009) Costeffectiveness of implementing low-tidal volume ventilation in patients with acute lung injury. Chest 136: 79-88.
  19. Spragg RG, Taut FJ, Lewis JF, Schenk P, Ruppert C, et al. (2011) Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury. Am J Respir Crit Care Med 183:1055-106.
  20. Spragg RG, Masys DR, Sergeant D, Lawrie T, Taut FJ (2010) An informatics strategy to assure enrollment criteria compliance in studies of the critically ill. Contemp Clin Trials 31: 530-535.
  21. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, et al. (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824.
  22. Rubenfeld GD (2004) Implementing effective ventilator practice at the bedside. Curr Opin Crit Care 10: 33-39.
  23. Wolthuis EK, Kesecioglu J, Hassink LH, Determann RM, Korevaar JC, et al. (2007) Adoption of lower tidal volume ventilation improves with feedback and education. Respir Care 52: 1761-1766.
  24. Eisner MD, Thompson BT, Schoenfeld D, Anzueto A, Matthay MA, et al. (2002) Airway Pressures and Early Barotrauma in Patients with Acute Lung Injury and Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 165: 978-982.
  25. Kallet RH, Jasmer RM, Pittet JF, Tang JF, Campbell AR, et al. (2005) Clinical implementation of the ARDS network protocol is associated with reduced hospital mortality compared with historical controls. Crit Care Med 33: 925-929.
  26. Esteban A, Ferguson ND, Meade MO, Frutos-Vivar F, Apezteguia C, et al. (2008) Evolution of mechanical ventilation in response to clinical research. Am J Respir Crit Care Med 177: 170-177.
  27. Bream-Rouwenhorst HR, Beltz EA, Ross MB, Moores KG (2008) Recent developments in the management of acute respiratory distress syndrome in adults. Am J Health Syst Pharm 65: 29-36.
Citation: Taut FJH, Bothe G, Schenk P, Dean N, Krell K, et al. (2011) Strategies for Achieving the Goals of a Lung-Protective Ventilation Protocol in Large Clinical Trials. J Clinic Trials 1:101.

Copyright: © 2011 Taut FJH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.